CLS Holdings USA Inc (CLSH)
0.05
0.00 (0.00%)
USD |
OTCM |
May 03, 16:00
CLS Holdings USA Debt to Equity Ratio: -0.6786 for Feb. 29, 2024
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| February 29, 2024 | -0.6786 |
| November 30, 2023 | -0.8163 |
| August 31, 2023 | -0.8439 |
| May 31, 2023 | -0.9124 |
| February 28, 2023 | -1.314 |
| November 30, 2022 | -1.511 |
| August 31, 2022 | -1.291 |
| May 31, 2022 | -1.358 |
| February 28, 2022 | -1.423 |
| November 30, 2021 | -1.341 |
| August 31, 2021 | -1.376 |
| May 31, 2021 | -1.329 |
| Date | Value |
|---|---|
| February 28, 2021 | -1.724 |
| November 30, 2020 | -2.533 |
| August 31, 2020 | -2.791 |
| May 31, 2020 | -3.270 |
| February 29, 2020 | 0.79 |
| November 30, 2019 | 0.7732 |
| August 31, 2019 | 0.6999 |
| May 31, 2019 | 0.7378 |
| February 28, 2019 | 0.46 |
| November 30, 2018 | 0.1721 |
| August 31, 2018 | 0.1437 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
-3.270
Minimum
May 2020
0.79
Maximum
Feb 2020
-1.076
Average
-1.321
Median
Debt to Equity Ratio Benchmarks
| NovaBay Pharmaceuticals Inc | 0.3431 |
| Palatin Technologies Inc | 0.00 |
| iBio Inc | -- |
| Theriva Biologics Inc | -- |
| Oragenics Inc | -- |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 9.130M |
| Total Liabilities (Quarterly) | 20.65M |
| Shareholders Equity (Quarterly) | -10.38M |
| Current Ratio | 0.3046 |
| Net Debt Paydown Yield | 15.81% |